Singapore, London----Influencer healthcare authorities the largest being the US Food and Drug Administration and the European Commission are taking a cautious approach to regulating medical mobile apps. Most mobile apps or stand-alone software that run on mobile devices are considered as having low risk, and not subject to the full pre-market scrutiny required of conventional medical devices. The reason for keeping an arm's length to digital healthcare apps or software is to give breathing room for more innovation in this space. Despite this easement, it does not mean that healthcare apps are completely scot-free of the regulatory net. The infographics below illustrate factors that turn medical mobile apps into regulated medical devices.

1. When Mobile Apps Become Medical Devices

2. US FDA Guidance on Mobile Medical Applications

3. UK MHRA Guidance on Medical Device Stand-Alone Software Including Apps

4. EC Guidelines on the Qualification of Stand Alone Software used in Healthcare

Original article: http://medtechupdates.semoegy.com/2015/03/comparison-of-medical-mobile-app-regulatory-frameworks/

Company Overview :

About Semoegy Advisers & Ventures

A former CEO of a successful CRO startup in Singapore from 2003 to 2008, Dr. Nealda Yusof's experience in the medical technology sector spans 14 years.